JAK1/2 Inhibition Modulates Key Markers of Lymphomagenesis in 9p24.1 Amplified Lymphoma, Priming for Enhanced Antigenicity

Tolu, S. S., Piorczynski, T. B., Pazos, M., Estrella, B., Huang, W., Ryu, Y. K., Cherng, H.-J. J., Pro, B., & Amengual, J. E. (2023). JAK1/2 Inhibition Modulates Key Markers of Lymphomagenesis in 9p24.1 Amplified Lymphoma, Priming for Enhanced Antigenicity. Blood, 142(Supplement 1), 6118–6118. https://doi.org/10.1182/blood-2023-180875
Authors:
Seda S. Tolu
Ted B. Piorczynski
Manuel Pazos
Brian Estrella
Wenxuan Huang
Yun Kyoung Ryu
Hua‐Jay J. Cherng
Barbara Pro
Jennifer E. Amengual
Affiliated Authors:
Seda S. Tolu
Ted B. Piorczynski
Manuel Pazos
Brian Estrella
Wenxuan Huang
Yun Kyoung Ryu
Hua‐Jay J. Cherng
Barbara Pro
Jennifer E. Amengual
Columbia Affiliation:
Subjects:
Lymphoid Neoplasms (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Acute Myeloid Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-180875
DOI:
10.1182/blood-2023-180875
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: